Date | Dividend Yield | Free Cash Flow Yield | Earnings Yield | Enterprise Value (EV) |
---|
CEO | Mr. Ameya Ashok Chandavarkar |
IPO Date | July 1, 2002 |
Location | India |
Headquarters | C/3, Skyvistas |
Employees | 6,659 |
Sector | Health Care |
Industries |
FDC Limited manufactures and markets pharmaceutical products in India and internationally. The company offers specialized formulations for various therapeutic segments, including anti-infective, gastrointestinal, ophthalmological, vitamins/minerals/dietary supplements, cardiac, anti-diabetes, respiratory, gynecology, dermatology, analgesics, and others; and oral rehydration salts. It provides specialized formulations primarily under the Zifi, Electral, Enerzal, Vitcofol, Pyrimon, Zocon, Zoxan, Zathrin, Zipod, Zefu, Cotaryl, and Mycoderm brand names. The company also offers anti-oxidants, balanced energy drinks, and vitamins and nutraceuticals under the Enerzal, Humyl, Mum Mum 1, Prosoyal, Simyl-LBW, Simyl-MCT, and Zefrich brands. In addition, it provides various active pharmaceutical ingredients. FDC Limited was founded in 1936 and is headquartered in Mumbai, India.
Past 5 years
USD 18.35
USD 11.66
USD 6.17
USD 3.76
USD 20.35
StockViz Staff
January 15, 2025
Any question? Send us an email